Supernus Pharmaceuticals | Eiendeler



Assets Endring Dato
Abbott USD 81.45B 34M 2025-03
ANI Pharmaceuticals USD 1.28B 3.68M 2024-12
Aurora Cannabis CAD 866.52M 57.75M 2024-12
Bristol-Myers Squibb USD 92.43B 176M 2025-03
Canopy Growth CAD 1.16B 68.13M 2024-12
Corcept Therapeutics USD 840.55M 56.3M 2024-12
Eisai JPY 1.43T 111.45B 2024-12
Eli Lilly USD 89.39B 10.67B 2025-03
Indivior 1.38B 56M 2025-03
Novo Nordisk 397.44B 28.06B 2024-09
Pacira USD 1.55B 31.82M 2024-12
Perrigo USD 9.65B 1.56B 2024-12
Pfizer USD 213.4B 6.08B 2024-12
Supernus Pharmaceuticals USD 1.37B 25.37M 2024-12
United Therapeutics USD 7.74B 379.9M 2025-03
Xeris Pharmaceuticals USD 323.06M 1.96M 2024-12



Supernus Pharmaceuticals Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.